All In MedTech

Device Trial Radar · NCT06076499

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

A Post-Market Observational Clinical Study to Determine the Long-Term Effectiveness and Safety of the Noctrix TOMAC (Tonic Motor Activation) System for the Treatment of Restless Legs Syndrome - The THRIVE Study

Last checked: Nov 19, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

325

Planned (sponsor's estimate)

Start

Nov 15, 2023

Primary completion

Jul 2026

Study completion Jul 2027

Sponsor

Lead sponsor
Noctrix Health, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years

Summary

As written by the sponsor on the registry.

Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.

Conditions

  • Restless Legs Syndrome

Interventions

  • NTX100Device

    NTX100 Tonic Motor Activation (TOMAC) System - a non-invasive peripheral nerve stimulation device programmed to deliver active stimulation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness EndpointTime frame: 1 year

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Mark J Buchfuhrer, MD Office

    Downey, California

  • Sleep Medicine Specialists of California

    San Ramon, California

  • Neurocare, Inc.

    Newton, Massachusetts

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.